Ensuring access to healthcare and medically necessary food for children
This bill requires certain Massachusetts health insurance plans to cover the cost of “medically necessary food” for children under 18 who have a food protein allergy. The bill defines food protein allergy broadly to include IgE and non-IgE mediated allergies, food protein-induced enterocolitis syndrome, and eosinophilic disorders such as eosinophilic esophagitis, gastroenteritis, and colitis. It also defines medically necessary food to include low-protein modified foods, amino acid-based formulas, modified fat products, and nutritional formulas used under medical supervision for dietary management of these conditions.
The coverage mandate applies across multiple insurance categories, including state employee coverage, commercial health insurance, hospital service plans, medical service agreements, health maintenance contracts, and preferred provider contracts. Plans must cover medically necessary food from in-network suppliers, may not raise patient cost sharing to comply, and may not require a primary care referral for specialty care from an immunologist or family practitioner when the care relates to medically necessary food for an eligible child. The bill also prohibits insurers from classifying this coverage as durable medical equipment. The Division of Insurance must adopt implementing regulations within six months of enactment.
The bill would amend several chapters of the General Laws governing public employee health coverage and private insurance regulation, including chapters 32A, 175, 176A, 176B, 176G, and 176I. It creates a new statutory coverage requirement for medically necessary food for minors with food protein allergies and limits insurer practices that could restrict access, such as referral requirements and cost-sharing increases. The bill would therefore expand mandated benefits and impose new compliance obligations on carriers, insurers, and health plans operating in Massachusetts.
The available context suggests generally favorable treatment of the bill, as the Senate Committee on Health Care Financing reported it ought to pass with an amendment replacing the original bill with a new draft. No recorded floor votes or committee transcripts are provided, but the committee recommendation indicates support for the underlying policy goal of improving access to medically necessary nutrition for children with serious food allergies. The estimated cost is noted as greater than $100,000, suggesting the bill was considered significant in fiscal terms as well as policy terms.
The main policy issues appear to be cost and insurance administration. The committee filing flags an estimated cost greater than $100,000, which may be a point of concern for insurers and budget-minded lawmakers. The bill also limits insurer discretion by prohibiting increased cost sharing, referral requirements, and classification of the benefit as durable medical equipment, which could draw resistance from carriers or administrators concerned about utilization management and plan design. At the same time, the bill’s supporters appear focused on ensuring access for children with medically documented allergies and related disorders.